Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 20
Filter
1.
Eur Ann Allergy Clin Immunol ; 56(1): 4-8, 2024 Jan.
Article in English | MEDLINE | ID: mdl-37671875

ABSTRACT

Summary: Background. Sensitization to food and airborne allergens is common in the majority of patients with eosinophilic esophagitis (EoE). Although there is not a direct cause-effect relationship of IgE-mediated allergy with the pathogenesis of EoE, there is a growing evidence that oral desensitization to food and sublingual immunotherapy (SLIT) may induce the development of EoE as an adverse effect. As part of the 'EoE and Allergen Immunotherapy (AIT)' Task Force funded by the European Academy of Allergy and Clinical Immunology (EAACI), a systematic approach will be followed to review the evidence from the published scientific literature on the development of EoE in children and adults under any type of AIT. Methods. This systematic review will be carried out following the PRISMA statement guidelines. Studies will be assessed for inclusion in the review according to the Population-Interventions-Comparators-Outcomes (PICO) criteria. Results. Expected outcomes will provide evidence on the AIT-EoE development connection. Conclusions. The findings from this review will be used as a reference to provide useful guidelines for physicians treating patients with EoE and/or are practicing AIT.


Subject(s)
Eosinophilic Esophagitis , Food Hypersensitivity , Adult , Child , Humans , Eosinophilic Esophagitis/etiology , Eosinophilic Esophagitis/therapy , Systematic Reviews as Topic , Meta-Analysis as Topic , Desensitization, Immunologic/adverse effects , Desensitization, Immunologic/methods , Allergens , Food Hypersensitivity/therapy
2.
Phys Med Biol ; 68(2)2023 01 11.
Article in English | MEDLINE | ID: mdl-36595320

ABSTRACT

Objective: Time-of-flight positron emission tomography (PET) is the next frontier in improving the effective sensitivity. To achieve superior timing for time-of-flight PET, combined with high detection efficiency and cost-effectiveness, we have studied the applicability of BaF2 in metascintillators driven by the timing of cross-luminescence photon production.Approach: Based on previous simulation studies of energy sharing and analytic multi-exponential scintillation pulse, as well as sensitivity characteristics, we have experimentally tested a pixel of 3 × 3 × 15 mm3 based on 300µm BGO and 300µm BaF2 layers. To harness the deep ultraviolet cross-luminescent light component, which carries improved timing, we use the FBK VUV SiPM. Metascintillator energy sharing is addressed through a double integration approach.Main results: We reach an energy resolution of 22%, comparable to an 18% resolution of simple BGO pixels using the same readout, through the optimized use of the integrals of the metascintillator pulse in energy sharing calculation. We measure the energy sharing extent of each pulse with a resolution of 25% and demonstrate that experimental and simulation results agree well. Based on the energy sharing, a timewalk correction is applied, exhibiting significant improvements for both the coincidence time resolution (CTR) and the shape of the timing histogram. We reach 242 ps CTR for the entire photopeak, while for a subset of 13% of the most shared events, the CTR value improves to 108 ps, comparable to the 3 × 3 × 5 mm3 LYSO:Ce:Ca reference crystal.Significance: While we are considering different ways to improve further these results, this proof-of-concept demonstrates the applicability of cross-luminescence for metascintillator designs through the application of VUV compatible SiPM coupling, and easily implementable digital algorithms. This is the first test of BaF2-based metascintillators of sufficient stoppng power to be included in a PET scanner, demonstrating the industrial applicability of such cross-luminescent metascintillators.


Subject(s)
Luminescence , Photons , Positron-Emission Tomography/methods , Ultraviolet Rays , Algorithms , Scintillation Counting/methods
4.
World Allergy Organ J ; 11(1): 32, 2018.
Article in English | MEDLINE | ID: mdl-30464782

ABSTRACT

BACKGROUND: Global chronic urticaria (CU) disease experience and management is not well documented. This study descriptively compares these aspects among CU patients residing in Europe (EU) and Central and South America (C/SA). METHODS: AWARE (A World-wide Antihistamine-Refractory chronic urticaria patient Evaluation) is a global prospective, non-interventional study of CU in the real-world setting. Patients were ≥ 18 years with a diagnosis of H1-antihistamine-refractory CU for > 2 months. Differences between the EU and C/SA regions in demographic and clinical characteristics, quality of life (QoL), work and activity impairment, pharmacological treatment, and healthcare resource use were examined. RESULTS: In total, 4224 patients were included in the analysis (C/SA 492; EU 3732). Rates of untreated patients were greater in the C/SA region (45.1% vs. 31.9%; P < 0.005) and escalation to third-line therapy was rare in both regions. Differences in disease experience emerged, with C/SA patients more commonly experiencing angioedema (C/SA 50.8% vs. EU 46.1%; P = 0.03) or comorbid chronic inducible urticaria (C/SA 30% vs. EU 22%; P < 0.001). Correspondingly, rates of uncontrolled urticaria were higher among C/SA patients (82.8% vs. 77.5%; P = 0.017) and patients in the C/SA region showed significantly greater work and activity impairment (absenteeism: 10.4 ± 19.7 vs. 6.7 ± 19.0, P = 0.004; presenteeism: 30.3 ± 31.9 vs. 24.4 ± 25.8, P = 0.001; work productivity loss: 33.9 ± 33.9 vs. 26.5 ± 27.5, P < 0.001; activity impairment: 37.7 ± 34.7 vs. 32.7 ± 30.1, P = 0.001). However, QoL impairment was greater in the EU region (Dermatology Life Quality Index: C/SA 6.5 ± 5.9 vs. EU 8.3 ± 7.0; P < 0.001). There was a significant difference in use of healthcare resources, including emergency services (39.6% vs. 29.3%; P < 0.001), hospitalization (7.7% vs 21.9%; P < 0.001) general practitioners (31.7% vs 57.3%; P < 0.001), and additional allergists or dermatologists (50.6% vs. 47.3%, P < 0.001), among patients in the C/SA and EU region, respectively. In both regions, patients with a primary diagnosis of CU with angioedema had significantly greater impairment in work and non-work activities and healthcare resource utilization compared to those without angioedema. CONCLUSIONS: This study revealed that CU is a heterogeneous condition with differences in healthcare utilization and outcomes between EU and C/SA. However, overall there is a high unmet need of H1-antihistamine-refractory CU patients, which is associated with high use of healthcare resources, and has a large negative effect on QoL and work productivity.

5.
Allergy ; 72(6): 849-856, 2017 Jun.
Article in English | MEDLINE | ID: mdl-28052339

ABSTRACT

BACKGROUND: There is a substantial body of evidence on the epidemiology of allergic conditions, which has advanced the understanding of these conditions. We aimed to systematically identify systematic reviews and meta-analyses on the epidemiology of allergic diseases to assess what has been studied comprehensively and what areas might benefit from further research. METHODS: We searched PubMed and EMBASE up to 12/2014 for systematic reviews on epidemiological research on allergic diseases. We indexed diseases and topics covered and extracted data on the search characteristics of each systematic review. RESULTS: The search resulted in 3991 entries after removing duplicates, plus 20 other items found via references and conference abstracts; 421 systematic reviews were relevant and included in this overview. The majority contained some evidence on asthma (72.9%). Allergic rhinitis, atopic eczema and food hypersensitivity were covered in 15.7%, 24.5% and 9.0%, respectively. Commonly studied risk factors for atopic eczema included dietary and microbial factors, while for asthma, pollution and genetic factors were often investigated in systematic reviews. There was some indication of differing search characteristics across topics. CONCLUSION: We present a comprehensive overview with an indexed database of published systematic reviews in allergy epidemiology. We believe that this clarifies where most research interest has focussed and which areas could benefit from further research. We propose that this effort is updated every few years to include the most recently published evidence and to extend the search to an even broader list of hypersensitivity/allergic disorders.


Subject(s)
Hypersensitivity/epidemiology , Asthma/epidemiology , Dermatitis, Atopic/epidemiology , Food Hypersensitivity/epidemiology , Humans , Review Literature as Topic , Rhinitis, Allergic/epidemiology
6.
Eur Ann Allergy Clin Immunol ; 48(5): 205-7, 2016 Sep.
Article in English | MEDLINE | ID: mdl-27608479

ABSTRACT

Omalizumab has been recently approved for treating patients with refractory to H1- antihistamines chronic spontaneous urticaria (CSU). Although hair loss is listed among omalizumab side effects, there are no available data to estimate its frequency. We describe for the first time hair loss as a side effect associated with omalizumab administration in three women, 38, 62 and 70 years old, suffering from refractory to H1-antihistamines CSU. This information was retrieved from their Chronic Urticaria Quality of Life Questionnaires. Despite this side effect, all patients agreed to continue omalizumab regular administration. Hair loss appeared to be transient, lasting up to four months. All cases finally benefited from omalizumab continuation.


Subject(s)
Alopecia/chemically induced , Anti-Allergic Agents/adverse effects , Omalizumab/adverse effects , Self Report , Urticaria/drug therapy , Adult , Aged , Alopecia/diagnosis , Chronic Disease , Female , Humans , Middle Aged , Quality of Life , Risk Factors , Time Factors , Urticaria/diagnosis , Urticaria/immunology
7.
Clin Exp Allergy ; 43(1): 116-27, 2013 Jan.
Article in English | MEDLINE | ID: mdl-23278886

ABSTRACT

BACKGROUND: Despite the frequency and severity of peanut allergy, the only approved treatment is strict avoidance. Different types of immunotherapy with crude peanut extract are not universally effective and have been associated with relatively high adverse reaction rates. OBJECTIVE: We sought to determine whether in silico predictive algorithms were useful in identifying candidate peptides for an Ara h 2 peptide-based vaccine using peanut-allergic patients' peripheral blood mononuclear cells (PBMCs) in vitro. A human leucocyte antigen (HLA) distribution analysis was also performed. METHODS: Major histocompatibility complex (MHC)-class II-binding peptides were predicted using NetMHCIIpan-2.0 and NetMHCII-2.2 algorithms. PBMCs from 80 peanut-allergic patients were stimulated with overlapping 20-mer Ara h 2 peptides. Cell supernatant cytokine profiles were evaluated by multiplex assays. HLA-DRB1* and HLA-DQB1* typing were performed. RESULTS: Four regions of overlapping sequences induced PBMC proliferation and predominant Th2 cytokine production. HLA genotyping showed 30 different DRB1* allele specificities and eight DQ serological specificities. The in silico analysis revealed similar relevant regions and predicted identical or similar core 9-mer epitopes to those identified in vitro. If relevant peptides, as determined by either in vitro or in silico analysis (15 peptides and 9 core epitopes respectively), were used in a peptide-based vaccine, they would cover virtually all subjects in the cohort studied. CONCLUSIONS AND CLINICAL RELEVANCE: Four dominant regions in Ara h 2 have been identified, containing sequences that could serve as potential candidates for peptide-based immunotherapy. MHC-class II-based T cell epitope prediction algorithms for HLA-DR and -DQ loci accurately predicted Ara h 2 T cell epitopes in peanut-allergic subjects, suggesting their potential utility in a peptide-based vaccine design for food allergy.


Subject(s)
2S Albumins, Plant/immunology , Antigens, Plant/immunology , Epitopes, T-Lymphocyte/immunology , Glycoproteins/immunology , Peanut Hypersensitivity/immunology , 2S Albumins, Plant/chemistry , Adolescent , Adult , Algorithms , Amino Acid Sequence , Antigens, Plant/chemistry , Child , Child, Preschool , Computer Simulation , Epitope Mapping , Epitopes, T-Lymphocyte/chemistry , Female , Glycoproteins/chemistry , Histocompatibility Antigens Class II/immunology , Humans , Male , Molecular Sequence Data , Young Adult
8.
Allergy ; 68(1): 27-36, 2013 Jan.
Article in English | MEDLINE | ID: mdl-23157716

ABSTRACT

An autoimmune subset of chronic spontaneous urticaria is increasingly being recognized internationally, based on laboratory and clinical evidence that has accrued over the last 20 years. This evidence has been reviewed by a taskforce of the Dermatology section of the European Academy of Allergy and Clinical Immunology. Functional autoantibodies in chronic urticaria (CU) patient sera have been demonstrated against IgE and FcεRIα by basophil and mast cell histamine release assays and by basophil activation assays. Antibody specificity has been confirmed by immunoassay, but there is a poor correlation between functionality and immunoreactivity. Approximately 25% of CU patients have a positive basophil histamine release assay and show autoreactivity (a positive autologous serum skin test), whereas 50% are negative regarding both. Functionality of CU sera appears to be complement dependent on mast cells but not exclusively on basophils. Basophil activation by CU sera is predominantly restricted to IgG1 and IgG3 subclasses. Circumstantial evidence for CU being an autoimmune disease comes from an observed association with other autoimmune diseases, a strong association between serum functionality and HLA-DR4 haplotype and the good response of CU patients to immunotherapies. It was proposed that a study should be undertaken to prospectively validate potentially relevant clinical criteria (from the history, examination and routinely available clinical investigations) against a new 'gold standard' for the diagnosis of ACU (positive autoreactivity, functional bioassay and immunoassay) to define preliminary criteria sets for the diagnosis of ACU based on clinical and laboratory features with highest individual sensitivity and specificity.


Subject(s)
Autoimmune Diseases/diagnosis , Urticaria/diagnosis , Urticaria/immunology , Autoantibodies/blood , Autoantibodies/immunology , Autoimmune Diseases/genetics , Autoimmune Diseases/therapy , Basophils/immunology , Basophils/metabolism , Cell Degranulation/immunology , Complement System Proteins , Histamine Release/immunology , Humans , Immunoglobulin G/blood , Immunoglobulin G/immunology , Immunotherapy , Mast Cells/immunology , Mast Cells/metabolism , Receptors, IgE/immunology , Urticaria/genetics , Urticaria/therapy
9.
Allergy ; 67(10): 1299-307, 2012 Oct.
Article in English | MEDLINE | ID: mdl-22913672

ABSTRACT

BACKGROUND: Fibrosis of the esophageal lamina propria is a known complication of eosinophilic esophagitis (EoE). To date, therapy with topical corticosteroids has been shown to reverse esophageal fibrosis in some patients; however, there is little evidence to suggest that dietary therapy can also reverse it. Our aim was to examine whether dietary therapy alone can reverse esophageal fibrosis in children with EoE. METHODS: We performed a historical cohort study based on children with EoE who had esophageal fibrosis on pretreatment biopsies using trichrome staining. Post-treatment biopsies were analyzed for fibrosis reversal, and results were compared between patients treated with dietary restriction and those that received topical steroids. Clinical characteristics (age, symptoms, duration of symptoms prior to therapy, treatment type, and duration of therapy) were recorded. Histological markers (eosinophil numbers and eosinophilic degranulation in both epithelium and lamina propria, basal zone hyperplasia, and the presence of eosinophilic microabscesses in the epithelium) were examined by reviewing hematoxylin and eosin-stained biopsies and by immunohistochemical staining. These were examined as potential predictors for fibrosis reversal. RESULTS: Fibrosis resolved following both dietary restriction and topical steroids (3/17 and 5/9 patients respectively, P = 0.078). Post-treatment symptom resolution and decreased intraepithelial eosinophil numbers were found to be the only significant predictors of fibrosis resolution. CONCLUSIONS: Dietary restriction alone, similar to topical steroids, can reverse fibrosis in children with EoE.


Subject(s)
Eosinophilic Esophagitis/complications , Epithelium/pathology , Esophagus/pathology , Fibrosis/diet therapy , Fibrosis/etiology , Adolescent , Adrenal Cortex Hormones/therapeutic use , Adult , Child , Child, Preschool , Cohort Studies , Eosinophilic Esophagitis/pathology , Female , Fibrosis/pathology , Humans , Male , Treatment Outcome , Young Adult
10.
Eur Ann Allergy Clin Immunol ; 43(2): 36-44, 2011 Mar.
Article in English | MEDLINE | ID: mdl-21608371

ABSTRACT

Pollen allergens of the Poaceae family comprise one of the main causes of pollinosis worldwide. Although most of cereals are included in this family, certain pollination characteristics and aerobiological features differentiate them from common wild grass pollen. Cereal pollen grains cannot be easily characterised as potential sources of aero allergens, because of their pollination mode (most of them are autogamous plants), the consecutive low numbers of pollen they produce and their pollen's large volume and consequent high weight which further prevent dispersion and pollen transport. However, various epidemiologicalstudies concluded in comparable sensitisation patterns between common grass and cereal pollen. This fact can be attributed to the common epitopes shared between grass and cereal pollen allergens, which are responsible for the high cross reactivity observed not only in vitro but also in vivo. Therefore, the sensitisation patterns do not usually reflect a genuine, cereal-specific IgE recognition. On the contrary, genuine cereal sensitisation and allergy are referred to only in rare cases of occupational exposure to high amounts of these pollen grains (farmers and field workers) or in patients staying in the vicinity of cereal fields. Thus, cautious considerations should be taken into account when diagnostically approaching patients in which cereal pollen allergy could be considered in the differential diagnosis.


Subject(s)
Edible Grain/immunology , Rhinitis, Allergic, Seasonal/therapy , Agriculture , Ecosystem , Humans , Rhinitis, Allergic, Seasonal/etiology
11.
Allergy ; 66(4): 458-68, 2011 Apr.
Article in English | MEDLINE | ID: mdl-21087215

ABSTRACT

A major part of the burden of asthma is caused by acute exacerbations. Exacerbations have been strongly and consistently associated with respiratory infections. Respiratory viruses and bacteria are therefore possible treatment targets. To have a reasonable estimate of the burden of disease induced by such infectious agents on asthmatic patients, it is necessary to understand their nature and be able to identify them in clinical samples by employing accurate and sensitive methodologies. This systematic review summarizes current knowledge and developments in infection epidemiology of acute asthma in children and adults, describing the known impact for each individual agent and highlighting knowledge gaps. Among infectious agents, human rhinoviruses are the most prevalent in regard to asthma exacerbations. The newly identified type-C rhinoviruses may prove to be particularly relevant. Respiratory syncytial virus and metapneumovirus are important in infants, while influenza viruses seem to induce severe exacerbations mostly in adults. Other agents are relatively less or not clearly associated. Mycoplasma and Chlamydophila pneumoniae seem to be involved more with asthma persistence rather than with disease exacerbations. Recent data suggest that common bacteria may also be involved, but this should be confirmed. Although current information is considerable, improvements in detection methodologies, as well as the wide variation in respect to location, time and populations, underline the need for additional studies that should also take into account interacting factors.


Subject(s)
Asthma/microbiology , Bacterial Infections/complications , Respiratory Tract Infections/complications , Virus Diseases/complications , Acute Disease , Asthma/complications , Asthma/epidemiology , Bacterial Infections/epidemiology , Humans , Respiratory Tract Infections/epidemiology , Respiratory Tract Infections/microbiology , Virus Diseases/epidemiology
14.
Allergy ; 64(9): 1256-68, 2009 Sep.
Article in English | MEDLINE | ID: mdl-19650847

ABSTRACT

Injection of autologous serum collected during disease activity from some patients with chronic spontaneous urticaria (CU) into clinically normal skin elicits an immediate weal and flare response. This observation provides a convincing demonstration of a circulating factor or factors that may be relevant to the understanding of the pathogenesis and management of the disease. This test has become known as the autologous serum skin test (ASST) and is now widely practised despite incomplete agreement about its value and meaning, the methodology and the definition of a positive response. It should be regarded as a test for autoreactivity rather than a specific test for autoimmune urticaria. It has only moderate specificity as a marker for functional autoantibodies against IgE or the high affinity IgE receptor (FcepsilonRI), detected by the basophil histamine release assay, but high negative predictive value for CU patients without them. It is usually negative in other patterns of CU, including those that are physically induced. Positive ASSTs have been reported in some subjects without CU, including those with multiple drug intolerance, patients with respiratory allergy and healthy controls, although the clinical implications of this are uncertain. It is essential that failsafe precautions are taken to ensure that the patient's own serum is used for skin testing and aseptic procedures are followed for sample preparation and handling. CU patients with a positive ASST (ASST(+)) are more likely to be associated with HLADR4, to have autoimmune thyroid disease, a more prolonged disease course and may be less responsive to H1-antihistamine treatment than those with a negative ASST (ASST(-)) although more evidence is needed to confirm these observations conclusively.


Subject(s)
Autoantibodies/immunology , Serum/immunology , Skin Tests , Urticaria/blood , Urticaria/immunology , Advisory Committees , Chronic Disease , Histamine H1 Antagonists/therapeutic use , Histamine Release/immunology , Humans , Immunoglobulin E/immunology , Injections, Subcutaneous , Receptors, IgE/immunology , United Kingdom , Urticaria/diagnosis
15.
Clin Exp Dermatol ; 33(4): 383-9, 2008 Jul.
Article in English | MEDLINE | ID: mdl-18582231

ABSTRACT

Oral allergy syndrome (OAS) or pollen-fruit allergy syndrome represents a mucosal allergic contact urticaria in people sensitized to common pollens, due to IgE cross-reactivity between homologous pollen allergens and various plant foods. It is the most prevalent food allergy, affecting millions of people with respiratory allergies. Usually, symptoms are mild, self-limiting and localized to the oropharyngeal mucosa, although they may sometimes become generalized and life-threatening. Although patients usually recognize the offending foods, diagnosis may sometimes be complicated. Several clinical syndromes and association between pollens and plant-derived foods have been described. Crossreactivity on the basis of stringent immunological and allergological criteria can also occur in people without pollen sensitization or concomitant respiratory allergies, as in latex-fruit syndrome. The term 'food contact hypersensitivity syndrome' (FCHS) is proposed in this paper for the first time, to include all mucosal hypersensitivity reactions presenting with contact to food (both immunological and nonimmunological), whether due to crossreactivity with homologous plant-derived allergens or not. At this time, prophylaxis and treatment can only be attained by avoidance, even when symptoms are mild, with consequent impairment in quality of life. A better understanding of the pathophysiological mechanisms of FCHS and food allergy in general is essential for deeper insights and future emergence of effective therapies.


Subject(s)
Antigens, Plant/immunology , Food Hypersensitivity/etiology , Fruit/adverse effects , Rhinitis, Allergic, Seasonal/etiology , Urticaria/immunology , Vegetables/adverse effects , Antigen-Antibody Reactions , Diagnosis, Differential , Humans , Immunoglobulin E/immunology , Mucous Membrane/immunology , Patient Compliance , Pollen/immunology , Syndrome
16.
Clin Exp Allergy ; 38(3): 466-72, 2008 Mar.
Article in English | MEDLINE | ID: mdl-18269670

ABSTRACT

BACKGROUND: Immune responses to rhinovirus (RV) as well as direct effects of RV on respiratory epithelium may contribute to the induction of asthma exacerbations. OBJECTIVE: To evaluate the effect of the environment resulting from an atopic immune response on RV-induced epithelial inflammation, replication and cytotoxicity. METHODS: Peripheral blood mononuclear cells (PBMC) from atopic asthmatic subjects and matched controls (12 pairs) were isolated and stimulated by RVs. Human bronchial epithelial (BEAS-2B) cells were infected with RV in the presence of conditioned media from RV-stimulated PBMC cultures. IL-6, IL-8, RANTES and TGF-beta1 levels were measured by ELISA, RV-induced cytotoxicity by a colorimetric method and RV titres on Ohio-HeLa cells. RESULTS: RV-induced epithelial production of IL-6, IL-8 and RANTES was significantly lower, while TGF-beta1 was higher when cells were exposed to conditioned media from atopic asthmatic subjects compared with those from normal controls. Exposure to the 'atopic' environment also resulted in elevated RV titres and increased RV-induced cytotoxicity. CONCLUSIONS: Under the influence of an atopic environment, the epithelial inflammatory response to RV is down-regulated, associated with increased viral proliferation and augmented cell damage, while TGF is up-regulated. These changes may help explain the propensity of atopic asthmatic individuals to develop lower airway symptoms after respiratory infections and indicate a mechanism through which viral infections may promote airway remodelling.


Subject(s)
Asthma/blood , Bronchitis/metabolism , Bronchitis/virology , Inflammation Mediators/metabolism , Monocytes/metabolism , Picornaviridae Infections/metabolism , Rhinovirus , Adult , Antibody Formation , Asthma/etiology , Bronchi/drug effects , Bronchi/metabolism , Bronchi/pathology , Bronchitis/pathology , Cell Death , Cells, Cultured , Culture Media, Conditioned/pharmacology , Cytokines/biosynthesis , Epithelial Cells/drug effects , Epithelial Cells/metabolism , Epithelial Cells/pathology , Female , Humans , Hypersensitivity, Immediate/complications , Hypersensitivity, Immediate/immunology , Interferon-gamma/metabolism , Male , Picornaviridae Infections/physiopathology , Rhinovirus/growth & development , Transforming Growth Factor beta1/metabolism , Up-Regulation , Virus Replication/drug effects
17.
J BUON ; 12(4): 543-5, 2007.
Article in English | MEDLINE | ID: mdl-18067215

ABSTRACT

We report a rare case of a primary melanoma of the lung initially presenting with haemoptysis, which was diagnosed using 2 new immunohistochemistry markers and cytology with immunocytochemistry. A 67-year-old male underwent repeated major lung resections and died because of early recurrences of a primary pulmonary melanoma as detailed study excluded other primary foci. The diagnosis of the patient's last recurrence was achieved on a fine needle aspiration (FNA) specimen with immunocytochemistry. To the best of our knowledge this is the first case of primary pulmonary melanoma diagnosed by immunocytochemistry on FNA material.


Subject(s)
Antigens, Neoplasm/analysis , Biomarkers, Tumor/analysis , Lung Neoplasms/diagnosis , Melanoma/diagnosis , Neoplasm Proteins/analysis , Aged , Biopsy, Fine-Needle , Humans , Immunohistochemistry , Lung Neoplasms/pathology , MART-1 Antigen , Male , Melanoma/pathology
18.
Travel Med Infect Dis ; 5(4): 239-42, 2007 Jul.
Article in English | MEDLINE | ID: mdl-17574146

ABSTRACT

BACKGROUND: Between May and September of 2002, 256 soldiers of the Greek Army Forces in Cyprus developed a 3-day self-limited febrile illness. All clinical symptoms and laboratory findings are described. RESULTS: The responsible agent was a Cypriot strain of sandfly fever Sicilian virus (genus Phlebovirus family Bunyaviridae), identified and isolated from the blood samples of infected individuals who were characterized by an abrupt onset of high fever, arthralgias, myalgias, headache and lower back pain, followed by a post-infectious asthenia syndrome. The major laboratory findings included leucopenia, monoytosis in blood smear and mild elevation of both the aminotransferases. CONCLUSION: A Cypriot strain of sandfly fever Sicilian virus was responsible for a 3-day-fever syndrome among non-immune soldiers. Clinicians have to consider Sandfly fever in the differential diagnosis in patients with similar symptoms during their accommodation or just after their return from Cyprus, or any other Mediterranean countries, especially during summer when sandflies are active.


Subject(s)
Disease Outbreaks , Military Personnel , Phlebotomus Fever/epidemiology , Adolescent , Adult , Animals , Cyprus/epidemiology , Female , Humans , Male , Phlebotomus Fever/etiology , Phlebotomus Fever/virology , Phlebovirus , Travel
19.
Clin Microbiol Infect ; 12(2): 192-4, 2006 Feb.
Article in English | MEDLINE | ID: mdl-16441462

ABSTRACT

A major outbreak of febrile syndrome occurred during 2002 among the Greek Army forces in Cyprus. Serological and molecular investigations revealed that the causative agent was a Sicilian-like phlebovirus. A virus strain was isolated from a blood sample taken on the first day of the disease. Phylogenetic analysis of partial L RNA segment sequences revealed that the strain from Cyprus differed from sandfly Sicilian virus by 6.7% at the nucleotide level.


Subject(s)
Bunyaviridae Infections/epidemiology , Disease Outbreaks , Phlebovirus/isolation & purification , Adult , Blood/virology , Bunyaviridae Infections/physiopathology , Cyprus/epidemiology , Fever/epidemiology , Fever/virology , Humans , Molecular Sequence Data , Phlebovirus/classification , Phlebovirus/genetics , Phylogeny , RNA, Viral/genetics , Sequence Analysis, DNA , Sequence Homology
20.
J BUON ; 11(1): 69-73, 2006.
Article in English | MEDLINE | ID: mdl-17318955

ABSTRACT

PURPOSE: To prospectively study the perioperative changes in serum magnesium (sMg) after major lung resections and their effect to the generation of cardiac dysrhythmias, and to present a brief review of the literature surrounding this phenomenon. PATIENTS AND METHODS: We studied 33 patients with non small cell lung cancer (NSCLC), scheduled for major pulmonary resection. Three patients were excluded from the study due to preoperative medication with beta-blocker and calcium (Ca) antagonists. Pneumonectomy was performed in 10 patients and lobectomy in 20. Heparinized arterial blood samples for the assessment of sMg, potassium (K) and Ca concentration were obtained before surgery, on arrival to the High Dependency Unit (HDU), and on the morning of the first and the second postoperative day. No patient had evidence of cardiac disease. RESULTS: Atrial fibrillation occurred in 3 (10%) patients. There was no statistically significant association between sMg and dysrhythmias. A statistically significant difference after adjusting for age was found between sMg concentration, just after the operation and the first post-operative day and the baseline measurement (before the operation). The type of surgical procedure was not found to be associated with the sMg concentration or the appearance of dysrhythmia. The serum K and Ca concentration for all samples was within normal range. CONCLUSION: Serum concentration of Mg decreases significantly within the first 24 hours of major lung resection. Although our study didn't demonstrate a relationship between decreases in sMg and the generation of arrhythmias, this link is well established in other fields and thus we support the prophylactic MgSO(4) administration in their prevention in such cases whilst we await further larger studies.


Subject(s)
Carcinoma, Non-Small-Cell Lung/surgery , Lung Neoplasms/surgery , Magnesium Deficiency/complications , Magnesium/blood , Postoperative Complications , Tachycardia, Supraventricular/etiology , Adult , Aged , Carcinoma, Non-Small-Cell Lung/blood , Electrocardiography, Ambulatory , Female , Humans , Lung Neoplasms/blood , Male , Middle Aged , Pneumonectomy/methods , Prognosis , Prospective Studies
SELECTION OF CITATIONS
SEARCH DETAIL
...